Zhao Rong, Zhang Jianyong, Gou Qingxiang, Gao Jinnan
General Surgery Department, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Third Hospital of Shanxi Medical University, Taiyuan, People's Republic of China.
Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Taiyuan, People's Republic of China.
Breast Cancer (Dove Med Press). 2023 Aug 10;15:577-589. doi: 10.2147/BCTT.S416998. eCollection 2023.
The role of traditional Chinese medicine (TCM) in breast cancer treatment is controversial. The aim of this study is to explore the popularity of TCM among the breast cancer patients who have been treated with Western medicine (WM) in north China.
An observational, cross-sectional study was conducted. We consecutively recruited 691 breast cancer patients who were diagnosed in Shanxi Bethune Hospital between 1 January 2017 and 31 December 2020 and completed follow-up between June and August 2022. A self-designed questionnaire was used for data collection. Participants were asked about TCM use by phone. Univariate and multivariate analyses were performed as appropriate.
At median follow-up of 41 months (range, 17-61 months), 326 (47.2%) participants used TCM. The results of multivariate logistic regression showed that residential area, education, annual income per capita, experienced TCM treatment before, stage of diagnosis, and trust in TCM were independent predictors of TCM use. The detail of TCM use and the reason for non-TCM use were presented comprehensively.
The use of TCM was prevalent among breast cancer patients treated with WM in north China. If WM physician encourage the patients with higher intention to use TCM and provide them with appropriate advices, the quality of life of patients will be further improved through integrating TCM into standard adjuvant therapy.
中医在乳腺癌治疗中的作用存在争议。本研究旨在探讨中医在华北地区接受西医治疗的乳腺癌患者中的普及程度。
进行了一项观察性横断面研究。我们连续招募了691例于2017年1月1日至2020年12月31日在山西白求恩医院确诊并于2022年6月至8月完成随访的乳腺癌患者。使用自行设计的问卷进行数据收集。通过电话询问参与者使用中医的情况。酌情进行单因素和多因素分析。
在中位随访41个月（范围17 - 61个月）时，326名（47.2%）参与者使用了中医。多因素逻辑回归结果显示，居住地区、教育程度、人均年收入、既往是否接受过中医治疗、诊断分期以及对中医的信任是使用中医的独立预测因素。全面呈现了中医使用的详细情况和未使用中医的原因。
在华北地区接受西医治疗的乳腺癌患者中，中医的使用较为普遍。如果西医医生鼓励有较高使用中医意愿的患者并为他们提供适当建议，通过将中医纳入标准辅助治疗，患者的生活质量将得到进一步改善。
